Blood Market Grow $10,253 million, Globally, by 2027 At 4.5% CAGR

Rise in demand for blood plasma to treat the COVID-19 patients creates new opportunities for the market player in the coming years.

NE WIN SIVERS DRIVE, PORTLAND, UNITED STATES, January 11, 2022 /EINPresswire.com/ -- Surge in plasma and blood donations across the globe and growing advancement in blood screening and blood transfusion instruments drive the growth of the global blood market. However, high cost associated with advanced blood collection devices hinders the market growth. On the other hand, rise in demand for blood plasma to treat the COVID-19 patients creates new opportunities for the market player in the coming years.

According to the report published by Allied Market Research, the Global blood market generated $7.2 billion in 2019, and is estimated to reach $10.25 billion by 2027, registering a CAGR of 4.5% from 2020 to 2027.The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios.

Leading market players analyzed in the research include Bio-Rad Laboratories, Abbott Laboratories, CSL Limited (CSL Behring),Bio-Rad Laboratories, Inc., Grifols International SA, F. Hoffmann-La Roche Ltd., Merck & Co., Inc.,Haemonetics Corporation, Ortho Clinical Diagnostics, and Novo Nordisk A/S.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/2297

Covid-19 scenario:

There has been cancellation of blood drives amid lockdown and implementation of social distancing rules has decreased the number of blood donors across the globe.

Governments have been appealing patients recovered from the Covid-19 to donate their plasma for infected patients. The report offers a detailed segmentation of the global blood market based on product, end-user, and region.

Based on product, the white blood collection and processing segment contributed to the largest share in 2019, accounting for more than half of the total share, and is estimated to maintain its dominant position during the forecast period. However, the source plasma collection segment is estimated to portray the highest CAGR of 6.4% during the forecast period.

Based on end user, the blood and blood component bank segment accounted for the largest share in 2019, holding more than one-third of the total share, and is expected to maintain the largest share throughout the forecast period. In addition, the segment is expected to register the highest CAGR of 5.4% from 2020 to 2027.

Based on region, North America contributed the highest share, accounting for around two-fifthsof the total market share in 2019, and will maintain its dominance throughout the forecast period. However,Asia-Pacific is expected to grow at the highest CAGR of 6.2% from 2020 to 2027.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2297

Get more information: https://www.alliedmarketresearch.com/library-access

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn